Tesamorelin
Stabilized GHRH Analog
- Form
- Lyophilized powder
- Storage
- -20°C (lyophilized)
- Origin
- USA lab
from$105
Tesamorelin is a synthetic stabilized GHRH-analog reference material used in laboratory investigations of GHRH-receptor activity and adipose-tissue signaling research.
- GHRH-receptor signaling research
- Adipose-signaling pathway studies
- In-vitro receptor-response models
SKU: AP-TESAMORELIN-10MG
3 vial minimum per order — mix any products
Research Use Only
All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.
Reconstitution ReferenceOptional — how strong is the mixed vial?
Mixing a powder vial with water? Fill in the fields — results update as you type.
Mixing 10 mg of peptide into 2 mL of water makes a 5 mg/mL solution. Each 0.1 mL contains 0.5 mg.
Reference for in-vitro laboratory handling only. Outputs describe the physical properties of the reconstituted vial (concentration and mass drawn) — they are not dosing guidance, administration instructions, or medical advice. Verify all measurements independently.
The science behind Tesamorelin
A structured overview of the published literature surrounding Tesamorelin as a stabilized GHRH-analog research peptide.
Tesamorelin is a synthetic stabilized analog of growth-hormone-releasing hormone (GHRH), modified with an N-terminal trans-3-hexenoyl group to resist enzymatic degradation. It is studied as a reference material for GHRH-receptor and adipose-signaling research.
The peptide is referenced in neuroendocrine and metabolic literature, particularly in models examining visceral-adipose signaling.
The material supplied here is a laboratory reference standard, and the summaries below describe only findings reported in published research.
Tesamorelin was engineered by adding a stabilizing N-terminal group to a GHRH sequence, extending stability relative to native GHRH for research and clinical study.
The literature includes preclinical and clinical neuroendocrine and metabolic research examining GHRH-receptor signaling and adipose-tissue effects.
The primary mechanism studied is agonism at the GHRH receptor, reported to stimulate cAMP-dependent growth-hormone release from pituitary-cell models.
Researchers also study downstream effects on lipolysis and visceral-adipose signaling in preclinical metabolic models.
GHRH-receptor assays
Used as a stabilized reference agonist in GHRH-receptor studies.
Adipose-signaling models
Examined in preclinical visceral-adipose and lipolysis research.
Neuroendocrine research
Studied in GHRH-axis and growth-hormone-regulation systems.
Metabolic models
Referenced in preclinical energy-metabolism research.
What is Tesamorelin?
A synthetic stabilized GHRH-analog peptide supplied as a laboratory reference material for GHRH-receptor and adipose-signaling research.
What kind of research references Tesamorelin?
Neuroendocrine and metabolic models of GHRH-receptor activation and visceral-adipose signaling.
Is Tesamorelin approved for human or veterinary use?
No. Tesamorelin is not approved by the FDA or any regulatory authority for human or animal use. It is sold exclusively for in-vitro and laboratory research and is not for consumption.
How is the reference material characterized?
Each released lot is supplied as a lyophilized powder with a lot-specific certificate of analysis reporting HPLC purity of ≥ 99%. The certificate is tied to the specific released lot.
How should the compound be stored?
Lyophilized material is typically stored at -20°C, protected from light and moisture. Handling should follow standard laboratory practice for peptide reference materials. We do not provide reconstitution, dosing, or administration guidance.
- Falutz J, et al. Tesamorelin, a GHRH analogue, in the management of visceral adiposity. N Engl J Med (2007).
- Stanley TL, Grinspoon SK. Effects of tesamorelin on visceral fat and metabolism (review).
Links open a curated peer-reviewed search on PubMed. Allpointe Bio Research is not affiliated with the cited authors or publishers.
Research-Use Statement
The information above is provided for educational and scientific-reference purposes only and summarizes findings reported in the published preclinical and in-vitro literature. It is not medical advice and does not describe outcomes, benefits, or applications for humans or animals. Tesamorelin is supplied strictly as a laboratory reference material for in-vitro and research use only — it is not a drug or supplement, is not approved for human or veterinary use, and is not for consumption. Allpointe Bio Research does not provide clinical, dosing, reconstitution, or administration guidance.